Convincing the confidence to conquer COVID-19: From epidemiological intervention to laboratory investigation.
作者信息
Liu William J, Wu Guizhen
机构信息
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
出版信息
Biosaf Health. 2020 Dec;2(4):185-186. doi: 10.1016/j.bsheal.2020.11.005. Epub 2020 Nov 27.
Abstract
摘要
相似文献
1
Convincing the confidence to conquer COVID-19: From epidemiological intervention to laboratory investigation.坚定战胜新冠疫情的信心：从流行病学干预到实验室研究
Biosaf Health. 2020 Dec;2(4):185-186. doi: 10.1016/j.bsheal.2020.11.005. Epub 2020 Nov 27.
2
3
Phacoemulsification time and power requirements in phaco chop and divide and conquer nucleofractis techniques.超声乳化劈核及分而治之核碎裂技术中的超声乳化时间及能量需求
J Cataract Refract Surg. 2000 Sep;26(9):1374-8. doi: 10.1016/s0886-3350(00)00538-1.
4
Central corneal thickness assessment after phacoemulsification: Subluxation versus Divide-and-Conquer.白内障超声乳化术后中央角膜厚度评估：半脱位法与分而治之法对比
J Fr Ophtalmol. 2017 Nov;40(9):744-750. doi: 10.1016/j.jfo.2017.02.013. Epub 2017 Oct 17.
5
Accelerating Epidemiological Investigation Analysis by Using NLP and Knowledge Reasoning: A Case Study on COVID-19.利用自然语言处理和知识推理加速流行病学调查分析：以 COVID-19 为例。
AMIA Annu Symp Proc. 2021 Jan 25;2020:1258-1267. eCollection 2020.
6
The importance of surveillance in cases of and mortality from the COVID-19 epidemic in Belo Horizonte, Brazil, 2020.2020年巴西贝洛奥里藏特市新冠疫情病例及死亡病例监测的重要性。
Rev Bras Epidemiol. 2020;23:e200061. doi: 10.1590/1980-549720200061. Epub 2020 Aug 5.
7
A laboratory-based study of COVID-19 in Casablanca, Morocco.摩洛哥卡萨布兰卡市一项基于实验室的新冠肺炎研究。
J Public Health Afr. 2021 Dec 31;12(2):1458. doi: 10.4081/jphia.2021.1458.
8
[Analysis on the imported Coronavirus Disease 2019 related cluster epidemic in rural areas of Chengdu].[成都市农村地区输入性新型冠状病毒肺炎相关聚集性疫情分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Oct 6;55(10):1240-1244. doi: 10.3760/cma.j.cn112150-20210421-00396.
9
Challenges of epidemiological investigation work in the COVID-19 pandemic: a qualitative study of the epidemiology workforce in Guangdong Province, China.新冠疫情期间流行病学调查工作面临的挑战：对中国广东省流行病学工作人员的定性研究。
BMJ Open. 2022 Nov 15;12(11):e056067. doi: 10.1136/bmjopen-2021-056067.
10
Let's conquer COVID-19 and sustain our abilities.让我们战胜新冠疫情并保持我们的能力。
Spinal Cord Ser Cases. 2020 Apr 7;6(1):19. doi: 10.1038/s41394-020-0271-z.
引用本文的文献
1
Analytical Performance of a Novel Nanopore Sequencing for SARS-CoV-2 Genomic Surveillance.一种用于SARS-CoV-2基因组监测的新型纳米孔测序的分析性能
J Med Virol. 2024 Dec;96(12):e70108. doi: 10.1002/jmv.70108.
2
Back to Science in Searching for SARS-CoV-2 Origins.回归科学探寻新冠病毒起源
China CDC Wkly. 2023 Apr 7;5(14):315-317. doi: 10.46234/ccdcw2023.055.
3
First Discovery of Phenuiviruses within Diverse RNA Viromes of Asiatic Toad () by Metagenomics Sequencing.宏基因组测序首次发现亚洲蟾蜍（）多样化 RNA 病毒组中的 Phenuiviruses。
Viruses. 2023 Mar 14;15(3):750. doi: 10.3390/v15030750.
4
Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.2022 年北京地区 SARS-CoV-2 变异株的特征：一项流行病学和系统进化分析。
Lancet. 2023 Feb 25;401(10377):664-672. doi: 10.1016/S0140-6736(23)00129-0. Epub 2023 Feb 8.
5
A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding.一种针对 SARS-CoV-2 刺突受体结合域的强效中和纳米抗体及其紧密结合的结构基础。
Front Immunol. 2022 May 18;13:820336. doi: 10.3389/fimmu.2022.820336. eCollection 2022.
6
An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses.一种用于评估新型冠状病毒2型特异性T细胞反应的基于酶联免疫斑点法的调整免疫测定法。
Biosaf Health. 2022 Jun;4(3):179-185. doi: 10.1016/j.bsheal.2022.04.005. Epub 2022 Apr 28.
7
A COVID-19 T-Cell Response Detection Method Based on a Newly Identified Human CD8 T Cell Epitope from SARS-CoV-2 - Hubei Province, China, 2021.基于新鉴定的来自严重急性呼吸综合征冠状病毒2的人类CD8 T细胞表位的2019冠状病毒病T细胞反应检测方法——中国湖北省，2021年
China CDC Wkly. 2022 Feb 4;4(5):83-87. doi: 10.46234/ccdcw2021.258.
8
A Tale of Two Cities: From Influenza HxNy to SARS-CoV-z.双城记：从甲型HxNy流感到新型冠状病毒2型（SARS-CoV-2） （注：原文中的“z”推测有误，这里按照实际情况翻译为“2”）
China CDC Wkly. 2021 Dec 3;3(49):1052-1056. doi: 10.46234/ccdcw2021.256.
9
Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19.COVID-19 无症状期、有症状期和恢复期的免疫反应模式。
Biochim Biophys Acta Proteins Proteom. 2022 Feb 1;1870(2):140736. doi: 10.1016/j.bbapap.2021.140736. Epub 2021 Nov 11.
10
Let's Get Vaccinated for Both Flu and COVID-19: On the World Flu Day 2021.让我们同时接种流感疫苗和新冠疫苗：在2021年世界流感日。
China CDC Wkly. 2021 Oct 29;3(44):915-917. doi: 10.46234/ccdcw2021.227.
本文引用的文献
1
A Case of COVID-19 - Tianjin Municipality, China, November 7, 2020.一例2019冠状病毒病病例——中国天津市，2020年11月7日
China CDC Wkly. 2020 Nov 13;2(46):884-885. doi: 10.46234/ccdcw2020.241.
2
Reemergent Cases of COVID-19 - Dalian City, Liaoning Province, China, July 22, 2020.2020年7月22日中国辽宁省大连市新冠肺炎复发病例
China CDC Wkly. 2020 Aug 21;2(34):658-660. doi: 10.46234/ccdcw2020.182.
3
Reemergent Cases of COVID-19 - Xinfadi Wholesales Market, Beijing Municipality, China, June 11, 2020.2020年6月11日中国北京市新发地批发市场新冠肺炎复发病例
China CDC Wkly. 2020 Jul 3;2(27):502-504. doi: 10.46234/ccdcw2020.132.
4
Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface.冷冻食品行业的冷链运输可能导致目的地新冠病例再次出现：成功从进口冷冻鳕鱼包装表面分离出新冠病毒。
Biosaf Health. 2020 Dec;2(4):199-201. doi: 10.1016/j.bsheal.2020.11.003. Epub 2020 Nov 19.
5
SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）：对其历史、发病机制、传播、诊断和治疗的批判性综述
Biosaf Health. 2020 Dec;2(4):217-225. doi: 10.1016/j.bsheal.2020.11.002. Epub 2020 Nov 8.
6
Emerging HxNy Influenza A Viruses.新兴 HxNy 型流感病毒。
Cold Spring Harb Perspect Med. 2022 Feb 1;12(2):a038406. doi: 10.1101/cshperspect.a038406.
7
Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland.2019年中国大陆新型冠状病毒病疫情期间的流感活动情况。
Biosaf Health. 2020 Dec;2(4):206-209. doi: 10.1016/j.bsheal.2020.08.005. Epub 2020 Sep 2.
8
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020.2020年在北京新发地市场再次出现的新冠疫情中鉴定出的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的基因组特征。
Biosaf Health. 2020 Dec;2(4):202-205. doi: 10.1016/j.bsheal.2020.08.006. Epub 2020 Sep 2.
9
Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test .通过中和效率和进入抑制试验确定的假型严重急性呼吸综合征冠状病毒2系统的开发与有效性
Biosaf Health. 2020 Dec;2(4):226-231. doi: 10.1016/j.bsheal.2020.08.004. Epub 2020 Aug 21.
10
Tackling COVID-19: Insights from the Qinghai Province plague prevention and control (PPC) model.应对新冠疫情：青海省鼠疫防控模式的启示
Biosaf Health. 2020 Dec;2(4):187-192. doi: 10.1016/j.bsheal.2020.08.001. Epub 2020 Aug 5.
Zotero 插件